CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer
Read More
Study
This Stream includes all of our Study Flipbooks
-
-
Detection of molecular residual disease using personalized circulating tumor DNA assay in colorectal cancer patients undergoing resection of
Read More
-
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stage I to III Colorectal Cancer
Read More
-
A multicenter, prospective observational study to evaluate the impact of circulating tumor DNA guided therapy on patients with colorectal ca
Read More
-
ctDNA clearance and radiographic resolution of disease in response to dual checkpoint inhibition in metastatic microsatellite stable colorec
Read More
-
Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, towards assessment of adjuvant therapy effi
Read More
-
Early detection of circulating tumor DNA post-operatively enables discovery of resectable metastatic disease in a patient with colon cancer
Read More
-
Post-operative ctDNA monitoring in stage I colon cancer: A case report
Read More
-
Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair d
Read More
-
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
Read More
-
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
Read More
-
Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder
Read More
-
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients Wi
Read More
-
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
Read More
-
Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival.
Read More
-
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
Read More
-
Treatment response monitoring using a tumor-informed circulating tumor DNA test in an advanced triple negative breast cancer patient: A case
Read More
-
Reply to Di Cosimo et al.: Advancing circulating tumor DNA for recurrent breast cancer
Read More
-
Advancing Circulating Tumor DNA for Recurrent Breast Cancer
Read More
-
A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination gen
Read More
-
Loading More...
